{"name":"BankInvest Biomedical Venture","permalink":"bankinvest-biomedical-venture","crunchbase_url":"http://www.crunchbase.com/financial-organization/bankinvest-biomedical-venture","homepage_url":"http://www.biventure.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"45-77-30-91-81","description":"Biotech Investment group","email_address":"bioreq@bankinvest.dk","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jun 23 07:37:48 UTC 2009","updated_at":"Wed Jun 24 22:37:23 UTC 2009","overview":"<p>In 1998, BankInvest established the first of several venture funds focusing on biotechnology. Today, BankInvest Biomedical Venture has more than EUR 400 million under management. The majority of these are research-based European biotechnology companies dedicated to developing profitable pharmaceuticals for the treatment of human diseases. BankInvest Biomedical Venture has a track record of 13 exits, covering 2 US, 5 EU and 6 Danish companies.</p>","image":{"available_sizes":[[[150,19],"assets/images/resized/0005/0286/50286v1-max-150x150.png"],[[150,19],"assets/images/resized/0005/0286/50286v1-max-250x250.png"],[[150,19],"assets/images/resized/0005/0286/50286v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Sundkrogsgade 7","address2":"P.O. Box 2672, DK-2100 Copenhagen","zip_code":"","city":"","state_code":null,"country_code":"DNK","latitude":55.7097277,"longitude":12.5924108}],"relationships":[{"is_past":false,"title":"Partner","person":{"first_name":"Anders","last_name":"Fink Vadsholt","permalink":"anders-fink-vadsholt","image":{"available_sizes":[[[90,110],"assets/images/resized/0005/0290/50290v1-max-150x150.jpg"],[[90,110],"assets/images/resized/0005/0290/50290v1-max-250x250.jpg"],[[90,110],"assets/images/resized/0005/0290/50290v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Principal","person":{"first_name":"Charlotte","last_name":"Antonsen","permalink":"charlotte-antonsen","image":{"available_sizes":[[[90,110],"assets/images/resized/0005/0291/50291v1-max-150x150.jpg"],[[90,110],"assets/images/resized/0005/0291/50291v1-max-250x250.jpg"],[[90,110],"assets/images/resized/0005/0291/50291v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"unattributed","source_url":"http://www.f2g.com/18_Aug_2008.htm","source_description":"F2G Ltd completes Â£6.3million financing round to fund pre-clinical and clinical development","raised_amount":6300000,"raised_currency_code":"GBP","funded_year":2008,"funded_month":8,"funded_day":18,"company":{"name":"F2G","permalink":"f2g","image":{"available_sizes":[[[134,140],"assets/images/resized/0005/0273/50273v1-max-150x150.png"],[[134,140],"assets/images/resized/0005/0273/50273v1-max-250x250.png"],[[134,140],"assets/images/resized/0005/0273/50273v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Cap Funding Report","raised_amount":13960000,"raised_currency_code":"USD","funded_year":2006,"funded_month":9,"funded_day":26,"company":{"name":"Resistentia Pharmaceuticals","permalink":"resistentia-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"b","source_url":"","source_description":"Cap Funding Report","raised_amount":8010000,"raised_currency_code":"USD","funded_year":2005,"funded_month":3,"funded_day":1,"company":{"name":"LiPlasome Pharma","permalink":"liplasome-pharma","image":{"available_sizes":[[[150,55],"assets/images/resized/0009/2370/92370v1-max-150x150.jpg"],[[214,79],"assets/images/resized/0009/2370/92370v1-max-250x250.jpg"],[[214,79],"assets/images/resized/0009/2370/92370v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}